CTAP (TFA)
CTAP TFA is a potent, highly selective, and brain penetrant antagonist of μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID) .
Product Specifications
CAS Number
——
Field of Research
Immunology & Inflammation
Purity
>98% (HPLC)
Molecular Weight
——
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog